Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2011
Report date:
2011

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity)
Version / remarks:
adopted Feb. 1987
Qualifier:
according to guideline
Guideline:
EU Method B.3 (Acute Toxicity (Dermal))
Version / remarks:
adopted May 2008
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.1200 (Acute Dermal Toxicity)
Version / remarks:
adopted August 1998
Qualifier:
according to guideline
Guideline:
other: Japan MAFF Testing Guideline of 12 Nosan no. 8147
GLP compliance:
yes (incl. QA statement)
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
(5-ethyl-1,3-dioxan-5-yl)methyl acrylate
EC Number:
266-380-7
EC Name:
(5-ethyl-1,3-dioxan-5-yl)methyl acrylate
Cas Number:
66492-51-1
Molecular formula:
C10H16O4
IUPAC Name:
(5-ethyl-1,3-dioxan-5-yl)methyl acrylate
Details on test material:
- Name of test material (as cited in study report): Laromer LR 8887
- Physical state: clear, yellowish liquid
- Analytical purity: 78.1 g/100 g by H-NMR spectroscopy
- Purity test date: 2011-11-03
- Lot/batch No.: 110009P040
- Expiration date of the lot/batch: no data
- Stability under test conditions: guaranteed by sponsor
- Storage condition of test material: room temperature in the dark
- Other: density as determined by Bioassay: 1.098 g/ml

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Wiga GmbH, Sandhofer Weg 7, 97633 Sulzfeld, Germany
- Age at study initiation: males: app. 8 weeks, females: app. 12 weeks
- Weight at study initiation: males 228 - 237g, females: 209-211g
- Fasting period before study: no
- Housing: single in makrolon cages, type III
- Diet (e.g. ad libitum): VRF1(P); SDS Special Diets Services, 67122 Altrip, Germany ad lib.
- Water (e.g. ad libitum): tap water ad lib.
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22°C ± 3°C
- Humidity (%): 30 - 70%
- Photoperiod (hrs dark / hrs light): 12h/12h

Administration / exposure

Type of coverage:
semiocclusive
Vehicle:
unchanged (no vehicle)
Details on dermal exposure:
TEST SITE
- Area of exposure: app. 40cm²
- Type of wrap if used: semi-occlusive

REMOVAL OF TEST SUBSTANCE
- Washing (if done): rinsing with warm water
- Time after start of exposure: 24h

TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 1.82ml/kg b.w.

Duration of exposure:
24h
Doses:
2000mg/kg
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: several times on the day of exposure, at least once daily on each workday thereafter
- Frequency of weighing: shortly before administration, weekly thereafter
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, scoring of skin findings (30-60min after exposure, several times thereafter)

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD0
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
no mortality occured
Clinical signs:
other: no systemic clinical signs were observed. For local irritation, see table 1 (males) and table 2 (females)
Gross pathology:
no abnormalities noted

Any other information on results incl. tables

Table 1:

Nature and duration of local clinical signs(males)
Dose (mg/kg bw): 2000
Sex: male
Administration: 1
No. of animals: 5
Animal No.: R 954 R 955 R 956 R 957 R 958
Abnormalities:          
Erythema grade 1: d9 - d12 d7 - d9 d13 d6 - d9 d8 - d9
Erythema grade 2: d1 - d2;
d7 - d8
d1 - d2; d6 d1 - d2;
d9 - d12
d1 - d5 d1 - d2; d7
Erythema grade 3: d5 - d6 d5 d5 - d8 - d5 - d6
Edema grade 1: - d1 - d2 d1 - d2 d1 - d2 d1 - d2
Incrustations: d5 - d8 d5 - d6 d5 - d12 - d5 - d8
Scaling: d5 - d 13 d5 - d7; d9 d5 - d14 d5 - d8 d5 - d9
Sever scaling: - d8 - - -
Skin findings beyond the
application area:
- - d6 - d13 - -
Significant scratching
behavior
d2 - d6 d2 - d5 d2 - d6 d2 - d5 d2 - d6

d: day

Table 2:

Nature and duration of local clinical signs(females)
Dose (mg/kg bw): 2000
Sex: female
Administration: 1
No. of animals: 5
Animal No.: R 959 R 960 R 961 R 962 R 963
Abnormalities:          
Erythema grade 1: d12 - d13 d14 d12 - d13 d12 - d13 d14
Erythema grade 2: d1 - d2;
d8 - d9
d1 - d2;
d12 - d13
d1 - d2;
d7 - d9
d1 - d2 d1 - d2;
d12 - d13
Erythema grade 3: d5 - d7 d5 - d9 d5 - d6 d5 - d9 d5 - d9
Edema grade 1: d6 - d9 - - d6 -
Edema grade 2: - - - d5 -
Incrustations: d5 - d12 d5 - d14 d5 - d12 d5 - d14 d5 - d14
Scaling: d5 - d14 d5 - d14 d5 - d9 d5 - d14 d5 - d14
Skin findings beyond the
application area:
- d6 - d14 d6 - d9 d6 - d14 d6 - d14
Significant scratching
behavior
d1 - d5 d1 - d5 d2 d2 - d3 d1 - d5

Applicant's summary and conclusion

Interpretation of results:
practically nontoxic
Remarks:
Migrated information
Conclusions:
Under the conditions of this study the median lethal dose (LD50) of the test material after dermal application was found to be greater than 2000 mg/kg bw in male and female rats.
Executive summary:

In an acute dermal toxicity study (Limit Test), young adult Wistar rats (5 males and 5 females) were dermally exposed to a single dose of 2000 mg/kg bw of undiluted test item to the clipped skin (dorsal and dorso-lateral parts of the trunk) and covered by semi-occlusive dressing for 24 hours. The application area comprised at least 10% of the total body surface area. The animals were observed for 14 days. The following test item-related local effects were recorded during the course of the study:

· No mortality occurred

· No signs of systemic toxicity were observed in the animals

· Slight to moderate erythema (grade 1 to 3)

· Slight to well-defined edema (grade 1 to 2)

· Incrustations

· Scaling

· Severe scaling

· Skin findings beyond the application area

· Significant scratching behavior

· The mean body weight of the animals increased within the normal range throughout the study period

· No macroscopic pathologic abnormalities were noted in the animals examined at the end of the study.